logo

Monopar Therapeutics Inc (MNPR) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Monopar Therapeutics Inc’s current trading price is -56.00% away from its 52-week high, while its distance from the 52-week low is 181.12%. The stock’s price range for this period has been between $0.27 and $1.75 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.84 million for the day, a number notably lower than the average daily volume of 5.48 million over the last three months.

In terms of market performance, Monopar Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $1.75 on 05/30/23, and the lowest value was recorded at $0.27 on 11/27/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Monopar Therapeutics Inc (MNPR) has experienced a quarterly rise of 73.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.44M and boasts a workforce of 10 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5234, with a change in price of +0.4350. Similarly, Monopar Therapeutics Inc recorded 3,496,387 in trading volume during the last 100 days, posting a change of +129.85%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MNPR stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

MNPR Stock Stochastic Average

As of today, Monopar Therapeutics Inc’s raw stochastic average for the last 50 days stands at 32.44%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 75.01%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 41.84% and 25.35%, respectively.

MNPR Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 126.34% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 50.24%. Over the past 30 days, the price of MNPR has leaped by -6.78%. And in the last five days, it has surged by 20.61%.